Cardiology

ASH: High-dose gene transfer beneficial in severe hemophilia A

(HealthDay)—For men with severe hemophilia A, high-dose factor VIII gene transfer is associated with sustained normalization of factor VIII activity levels, according to a study published online Dec. 9 in the New England ...

page 1 from 6